conjugated hexavalent vaccine (GSK/Biological E)
N/A
Report date: 2025/03/18 20:00:05
Base Information
Drug Nameconjugated hexavalent vaccine (GSK/Biological E)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcBiological E Ltd
Active IndicationsN/A
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A